Population
Patients with Neuroleptic malignant syndrome (NMS) or Parkinson's disease withdrawn from medication
Design
Review
Key result
Neuroleptic malignant syndrome is a life-threatening complication characterized by functional dopamine deficiency, managed primarily by discontinuing causative drugs and providing supportive care.
Authors
Loading...
NMS is a life-threatening condition primarily caused by functional dopamine deficiency, requiring prompt recognition and discontinuation of triggering agents for a good outcome.
NMS is a life-threatening condition primarily caused by functional dopamine deficiency, requiring prompt recognition and discontinuation of triggering agents for a good outcome.
Kornhuber et al. (1994) conducted a review in Neuroleptic malignant syndrome. Neuroleptic malignant syndrome is a life-threatening complication characterized by functional dopamine deficiency, managed primarily by discontinuing causative drugs and providing supportive care.